Skip to main content

Peer Review reports

From: SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation

Original Submission
13 Apr 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
14 Apr 2012 Author responded Author comments - Daniele Tibullo
Resubmission - Version 3
14 Apr 2012 Submitted Manuscript version 3
17 Apr 2012 Author responded Author comments - Daniele Tibullo
Resubmission - Version 4
17 Apr 2012 Submitted Manuscript version 4
15 May 2012 Reviewed Reviewer Report - xueying wang
9 Jul 2012 Reviewed Reviewer Report - osvaldo podhajcer
31 Oct 2012 Author responded Author comments - Daniele Tibullo
Resubmission - Version 5
31 Oct 2012 Submitted Manuscript version 5
23 Nov 2012 Reviewed Reviewer Report - osvaldo podhajcer
27 Nov 2012 Reviewed Reviewer Report - xueying wang
21 Dec 2012 Author responded Author comments - Daniele Tibullo
Resubmission - Version 6
21 Dec 2012 Submitted Manuscript version 6
Publishing
16 Jan 2013 Editorially accepted
5 Feb 2013 Article published 10.1186/1471-2407-13-60

You can find further information about peer review here.

Back to article page